New diabetes drug burns fat, spares muscle
A new oral diabetes medication has shown the ability to lower blood sugar and increase fat burning without causing muscle loss, according to early clinical trial results. The drug works by activating metabolism in skeletal muscle tissue. Researchers said the treatment was safe and well-tolerated in initial human testing, offering a potential alternative to existing diabetes drugs that often cause muscle wasting or weight loss side effects.
GLP-1 drugs linked to lower addiction risk
A large-scale study of more than 600,000 U.S. veterans found that semaglutide, the active ingredient in GLP-1 drugs like Ozempic and Wegovy, is associated with a reduced likelihood of substance use disorders. The study showed lower risks for alcohol, nicotine, cannabis, and opioid use disorders among those taking the medication. The findings add to growing evidence that GLP-1 drugs may have benefits beyond diabetes and weight management.
Electrical neck implants restore arm function in stroke survivors
Researchers reported that electrical implants placed in the neck can immediately restore arm mobility in stroke survivors. The devices provided instant functional recovery in upper limbs, allowing patients who had lost arm function to perform tasks they could not manage before treatment. The approach offers new hope for the millions of stroke survivors worldwide with lasting motor impairments.